US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

NPCE

Neuropace (NPCE)

Neuropace Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NPCE

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	06 : 17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NPCE	Neuropace Inc
2024/05/09	05 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NPCE	Neuropace Inc
2024/03/06	07 : 48	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NPCE	Neuropace Inc
2024/03/06	06 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NPCE	Neuropace Inc
2024/02/29	10 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2024/02/29	10 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2024/02/29	10 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2024/02/15	06 : 15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NPCE	Neuropace Inc
2024/02/08	06 : 43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NPCE	Neuropace Inc
2024/02/07	09 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2024/02/02	23 : 20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NPCE	Neuropace Inc
2024/02/02	11 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2024/01/27	08 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2024/01/08	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NPCE	Neuropace Inc
2023/12/29	07 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2023/12/23	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2023/12/21	07 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NPCE	Neuropace Inc
2023/12/08	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2023/12/07	07 : 59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NPCE	Neuropace Inc
2023/12/05	07 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NPCE	Neuropace Inc
2023/12/02	11 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2023/12/02	11 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2023/11/30	07 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc
2023/11/30	03 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NPCE	Neuropace Inc
2023/11/07	06 : 55	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NPCE	Neuropace Inc
2023/11/07	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NPCE	Neuropace Inc
2023/08/09	06 : 22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NPCE	Neuropace Inc
2023/08/09	05 : 56	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NPCE	Neuropace Inc
2023/08/09	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NPCE	Neuropace Inc
2023/07/20	05 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NPCE	Neuropace Inc

Showing the most relevant articles for your search:NASDAQ:NPCE

1 2 3 4 5 次へ >>

Ubs Etf Msci Europe & Mi...

SGSA SPDR ETFs Europe II (PK)

Xvivo Perfusion AB (PK)

Foley Trasimene Acquisit...

Apex Critical Metals

CSNAS136 Ex:12,94

Current Water Technologies

Northwest Natural

ITUBG316 Ex:30,22

Evome Medical Technologies

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約